The Global ABM Conference 2025 delegate brochure is packed with all the information you'll need ahead of booking your ticket. Our second ever Global B2B Marketing Agencies Benchmarking Report is back ...
Bayer has its first regulatory approval for elinzanetant as a non-hormonal treatment for menopausal symptoms – in the UK – as it chases down a rival therapy from Astellas. The Medicines and Healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback